资讯

NeOnc Technologies Holdings, Inc.: NeOnc Technologies Announces Near Completion of Phase I ...
NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous ...
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer ...
NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced ...